Mary Kate Anderson

4PUBLICATIONS
6CO-AUTHORS
HaematologyNeurology and neuromuscular diseasesHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 09, 2022
A Review of Current and Emerging Therapeutic Options for Hemophagocytic Lymphohistiocytosis.

Jenna Summerlin, Drew A Wells, Mary Kate Anderson

|Sep 20, 2021
A Review of Selumetinib in the Treatment of Neurofibromatosis Type 1-Related Plexiform Neurofibromas.

Mary Kate Anderson, Meredith Johnson, Lauren Thornburg

|Aug 03, 2021
Brexucabtagene Autoleucel: A Novel Chimeric Antigen Receptor T-cell Therapy for the Treatment of Mantle Cell Lymphoma.

Mary Kate Anderson, Annie Torosyan, Zachery Halford

|Sep 18, 2020
Enfortumab Vedotin-ejfv: A First-in-Class Anti-Nectin-4 Antibody-Drug Conjugate for the Management of Urothelial Carcinoma.

Zachery Halford, Mary Kate Anderson, Matthew D Clark

Pageof 1